Which drug class is associated with hepatotoxicity?

Azole drugs are known to be associated with hepatotoxicity, primarily due to their mechanism of action and the way they are metabolized in the liver. This class of antifungal agents, which includes drugs like fluconazole and itraconazole, affects hepatic enzymes and can lead to increased liver enzymes in some patients.

The azole compounds inhibit the fungal cytochrome P450 enzyme system, which can disrupt liver function and elevate liver transaminases, leading to toxic effects on liver cells. Monitoring of liver function tests is often recommended when patients are on these medications, especially in those with existing liver issues or who are taking other medications that may also affect the liver.

The other drug classes listed do not have the same level of association with liver toxicity. For instance, Amphotericin B, while it can have significant side effects, is more commonly associated with renal toxicity than hepatotoxicity. Flucytosine does have some potential for toxicity, but its major concern is not specifically hepatotoxicity. Polyenes, which refer to drugs like Amphotericin B, are also less directly associated with liver toxicity compared to azole drugs. Therefore, the recognition of azole drugs as a class with hepatotoxic potential stands out clearly in this